AN OVERVIEW OF THE VI EULAR SCIENTIFIC EDUCATIONAL COURSE DEDICATED TO SYSTEMIC LUPUS ERYTHEMATOSUS (PISA, ITALY, SEPTEMBER 1–6, 2013)

by T. A. Panafidina
Published 2014-06-01

HEART FAILURE IN SYSTEMIC LUPUS ERYTHEMATOSUS: RISK FACTORS AND DIAGNOSTIC FEATURES

by T. A. Panafidina, T. V. Popkova
Published 2018-07-01

VENOARTERIAL DIFFERENCE OF PARTIAL TENSION OF CARBON DIOXIDE (ΔPCO2) AS A MARKER OF HYPOPERFUSION IN THE PATIENTS HAVING LAPAROSCOPIC SURGERY DUE TO COLORECTAL CANCER

by V. A. Panafidina, I. V. Shlyk
Published 2018-07-01

Goal-directed hemodynamic therapy in patients with colorectal cancer undergoing laparoscopic surgery

by V. A. Panafidina, I. V. Shlyk
Published 2020-03-01

General principles in the treatment of lupus nephritis with the prevention of cardiovascular events

by Т. A. Panafidina, Т. V. Popkova
Published 2018-12-01

Monitoring patients with systemic lupus erythematosus: general characteristics and discussion questions (according to the Canadian Rheumatology Association recommendations)

by T. A. Panafidina, T. V. Popkova, S. K. Solovyev
Published 2019-07-01

According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments

by T. V. Popkova, T. A. Panafidina, S. K. Solovyev
Published 2019-11-01

Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic

by E. L. Nasonov, T. V. Popkova, T. A. Panafidina
Published 2021-05-01

INFECTION COMPLICATIONS AFTER COLON-PROCTOLOGIC SURGERIES: EPIDEMIOLOGY, PATHOGENESIS AND PREVENTION

by I. V. Shlyk, A. A. Zakharenko, V. A. Panafidina, O. N. Ten
Published 2017-11-01

COMORBIDITY IN RHEUMATOID ARTHRITIS

by T. A. Panafidina, L. V. Kondratyeva, E. V. Gerasimova, D. S. Novikova, T. V. Popkova
Published 2014-06-01

Bioimpedance analysis in determining body composition in women with systemic lupus erythematosus: a pilot study

by L. V. Kondratyeva, T. A. Panafidina, T. V. Popkova, Yu. R. Varaeva, A. V. Starodubova
Published 2020-03-01

IMPACT OF INTRA-OPERATIVE INTRA-ABDOMINAL HYPERTENSION ON THE COURSE OF POST-OPERATIVE PERIOD IN THE PATIENTS UNDERGOING SURGERY FOR COLORECTAL CANCER

by I. V. Shlyk, A. A. Zakharenko, V. A. Panafidina, A. A. Trushin, O. A. Ten
Published 2018-01-01

Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis

by T A Panafidina, G V Popkova, Z S Alekberova, É S Mach, E N Aleksandrova, E L Nasonov
Published 2008-05-01

Diabetes mellitus and hyperglycemia in patients with rheumatoid arthritis

by L. V. Kondratyeva, T. A. Panafidina, E. V. Gerasimova, Yu. N. Gorbunova, T. V. Popkova, E. L. Nasonov
Published 2014-09-01

CLINICAL SIGNIFICANCE OF N-TERMINAL FRAGMENT OF NATRIURETIC PEPTIDE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO DO NOT RECEIVE PATHOGENETIC THERAPY

by T. A. Panafidina, M. A. Sokhova, T. V. Popkova, D. S. Novikova, E. N. Aleksandrova, Yu. O. Korsakova, A. V. Volkov
Published 2017-09-01

CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS

by T. A. Panafidina, M. A. Sokhova, T. V. Popkova, M. V. Cherkasova, A. A. Novikov, E. N. Aleksandrova, E. L. Nasonov
Published 2016-07-01

Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection

by T V Popkova, T A Panafidina, E N Aleksandrova, D S Novikova, A A Novikov, Z S Alekberova, É S Mach, E L Nasonov
Published 2008-05-01

ROLE OF INFLAMMATION MARKERS IN DEVELOPMENT OF ATHEROSCLEROSIS AND ITS COMPICATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

by Tatiyana Valentinovna Popkova, T A Panafidina, D S Novikova, E N Aleksandrova, A A Novikov, T E Novoselova, A N Gerasimov, E L Nasonov
Published 2014-02-01

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part I

by N. L. Kozlovskaya, S. K. Solovyev, E. A. Aseeva, T. V. Popkova, T. A. Panafidina, E. L. Nasonov, A. M. Lila, A. A. Mesnyankina, N. Yu. Nikishina
Published 2020-11-01

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II

by N. L. Kozlovskaya, S. K. Solovyev, E. A. Aseeva, T. V. Popkova, T. A. Panafidina, E. L. Nasonov, A. M. Lila, A. A. Mesnyankina, N. Yu. Nikishina
Published 2021-02-01